St. Louis MO 结肠癌临床试验
15项针对 结肠癌的研究正在 St. Louis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Family Communications After Genetic Testing
招募中欢迎健康志愿者
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- 以及另外 4 项
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
招募中欢迎健康志愿者
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- 以及另外 4 项
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, St Louis
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Washington University School of Medicine, St Louis
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
招募中2 期
- Missouri Baptist, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
招募中观察性研究
- Washington University School of Medicine, St Louis
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
招募中
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- 以及另外 1 项
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
招募中2/3 期
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- 以及另外 8 项
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
招募中
- Washington University School of Medicine, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- Washington University Infusion Center Pharmacy, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
招募中观察性研究欢迎健康志愿者
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- Washington University, St Louis
其他城市的 结肠癌试验
- Boston, MA22 项研究
- New York City, NY22 项研究
- Houston, TX20 项研究
- Los Angeles, CA16 项研究
- Nashville, TN16 项研究
- Arlington, VA15 项研究
- Chicago, IL14 项研究
- San Antonio, TX14 项研究
- Baldwin Park, CA14 项研究
- Baltimore, MD13 项研究
- Tampa, FL13 项研究
- Washington, DC12 项研究
St. Louis的其他研究
- 非小细胞肺癌73 项研究
- 乳腺癌64 项研究
- 转移性癌症54 项研究
- 结直肠癌50 项研究
- 癌症（所有类型）46 项研究
- 前列腺癌46 项研究
- 肺癌39 项研究
- 卵巢癌38 项研究
- 胰腺癌33 项研究
- 子宫内膜癌29 项研究
- 头颈鳞状细胞癌28 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。